- Home
- Publications
- Publication Search
- Publication Details
Title
Anthracycline cardiotoxicity
Authors
Keywords
-
Journal
Expert Opinion On Drug Safety
Volume 11, Issue sup1, Pages S21-S36
Publisher
Informa Healthcare
Online
2011-06-03
DOI
10.1517/14740338.2011.589834
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Anthracycline-related cardiomyopathy in childhood cancer survivors and association with polymorphisms in the carbonyl reductase genes: A Children's Oncology Group study.
- (2017) J. G. Blanco et al. JOURNAL OF CLINICAL ONCOLOGY
- Cardioprotective effect of metoprolol and enalapril in doxorubicin-treated lymphoma patients: A prospective, parallel-group, randomized, controlled study with 36-month follow-up
- (2010) Peter Georgakopoulos et al. AMERICAN JOURNAL OF HEMATOLOGY
- Integrating bevacizumab, everolimus, and lapatinib into current neoadjuvant chemotherapy regimen for primary breast cancer. Safety results of the GeparQuinto trial
- (2010) G. von Minckwitz et al. ANNALS OF ONCOLOGY
- Cardiotoxicity of anthracycline agents for the treatment of cancer: Systematic review and meta-analysis of randomised controlled trials
- (2010) Lesley A Smith et al. BMC CANCER
- Impact of ABCB1 Allelic Variants on QTc Interval Prolongation
- (2010) T. M. Sissung et al. CLINICAL CANCER RESEARCH
- Trastuzumab-Induced Cardiotoxicity: Clinical and Prognostic Implications of Troponin I Evaluation
- (2010) Daniela Cardinale et al. JOURNAL OF CLINICAL ONCOLOGY
- An open-label expanded access study of lapatinib and capecitabine in patients with HER2-overexpressing locally advanced or metastatic breast cancer
- (2009) G. Capri et al. ANNALS OF ONCOLOGY
- Pegylated liposomal doxorubicin and trastuzumab as 1st and 2nd line therapy in her2/neu positive metastatic breast cancer: a multicenter phase II trial
- (2009) Elmar Stickeler et al. BREAST CANCER RESEARCH AND TREATMENT
- Trastuzumab versus lapatinib: The cardiac side of the story
- (2009) Hamdy Azim et al. CANCER TREATMENT REVIEWS
- Anthracyclines and Early Breast Cancer: The End of an Era?
- (2009) Luca Gianni et al. JOURNAL OF CLINICAL ONCOLOGY
- Doxorubicinolone Formation and Efflux: A Salvage Pathway against Epirubicin Accumulation in Human Heart
- (2009) E. Salvatorelli et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Twenty years of follow-up among survivors of childhood and young adult acute myeloid leukemia
- (2008) Daniel A. Mulrooney et al. CANCER
- Genetic polymorphisms in the carbonyl reductase 3 geneCBR3 and the NAD(P)H:quinone oxidoreductase 1 geneNQO1 in patients who developed anthracycline-related congestive heart failure after childhood cancer
- (2008) Javier G. Blanco et al. CANCER
- Cardiotoxicity of Antitumor Drugs†
- (2008) Pierantonio Menna et al. CHEMICAL RESEARCH IN TOXICOLOGY
- Nonpegylated Liposomal Doxorubicin (TLC-D99), Paclitaxel, and Trastuzumab in HER-2-Overexpressing Breast Cancer: A Multicenter Phase I/II Study
- (2008) J. Cortes et al. CLINICAL CANCER RESEARCH
- Late sodium current inhibition as a new cardioprotective approach
- (2008) Sharon L. Hale et al. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
- Deferiprone Does Not Protect against Chronic Anthracycline Cardiotoxicity in Vivo
- (2008) O. Popelova et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Evaluation of the topoisomerase II-inactive bisdioxopiperazine ICRF-161 as a protectant against doxorubicin-induced cardiomyopathy
- (2008) Elke Martin et al. TOXICOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now